Search Results
Oct 17, 2025, 03:48 ET Marengo Asia Hospitals acquires majority stake in 350-bed Sunshine Global Hospitals
Havells and Godrej family offices and Dr Raajiv Singhal and is one of the fastest growing unlisted hospital chains with a revenue run-rate of ~ INR 1,200crs p.a. Photo:
More news about: Marengo Asia Hospitals
Oct 16, 2025, 08:45 ET Cell Publishes Breakthrough Research Results of IASO Bio's Anti-BCMA CAR-T Equecabtagene Autoleucel in Autoimmune Disease Multiple Sclerosis
new/enlarging T2 lesions. Manageable safety profile: Only transient grade 1 cytokine release syndrome (CRS) occurred in 80% of patients, with no cases of ≥grade 2 CRS. No immune effector cell-associated neurotoxicity syndrome (ICANS) or other neurotoxic reactions were observed.
More news about: IASO Bio
Oct 16, 2025, 08:30 ET Dominari Securities Raises Over $1.4 Billion Year-to-Date in Support of American Innovation and Entrepreneurship
all of the principal invested. You can check the background of Dominari Securities and its registered investment professionals and review its SEC Form CRS on FINRA's BrokerCheck site at
More news about: Dominari Holdings Inc.
Oct 16, 2025, 08:00 ET TECVAYLI® plus DARZALEX FASPRO® combination regimen significantly improves progression-free survival and overall survival versus standard of care
release syndrome (CRS), including life-threatening or fatal reactions. In the clinical trial, CRS occurred in 72% of patients who received TECVAYLI® at the recommended dose, with Grade 1 CRS occurring in 50% of patients, Grade 2 in 21%, and Grade 3 in 0.6%. Recurrent CRS occurred in 33% of
More news about: Johnson & Johnson
Oct 15, 2025, 11:30 ET MLG CAPITAL PRINCIPAL AND SENIOR VICE PRESIDENT RYAN MUELLER SELECTED BY GLOBEST. AS A 2025 INFLUENCER IN MULTIFAMILY
FINRA/SIPC . Its Form CRS may be found
More news about: MLG Capital
Oct 14, 2025, 12:00 ET Mabwell Announces Latest Clinical Results of Novel B7-H3-Targeting ADC 7MW3711 to Be Presented at 2025 ESMO Congress
the phase I/II study. Among 54 patients treated at 4.0 mg/kg or above and reaching tumor assessment, 19 partial responses (PRs) or complete responses (CRs) were observed. 7 patients with esophageal cancer (EC) were enrolled at 4.0 mg/kg or above and achieved an objective response rate (ORR) of 42.9% and
More news about: Mabwell
Oct 10, 2025, 11:48 ET HEMI AND DOMINARI SECURITIES TO DEVELOP DIGITAL ASSET TREASURY AND ETF PLATFORMS
all of the principal invested. You can check the background of Dominari Securities and its registered investment professionals and review its SEC Form CRS on FINRA's BrokerCheck site at
More news about: Hemi
Oct 09, 2025, 08:00 ET Dominari Securities Receives Approval as a Limited Underwriting Member of the New York Stock Exchange
all of the principal invested. You can check the background of Dominari Securities and its registered investment professionals and review its SEC Form CRS on FINRA's BrokerCheck site at
More news about: Dominari Holdings Inc.
Oct 07, 2025, 20:15 ET CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology
0.1×106 CAR T cells/kg. Cytokine release syndrome occurred in 12 patients (60%), all graded as 1 or 2. No Grade ≥3 cytokine release syndrome (CRS) occurred. One patient (5%) experienced Grade 3 immune effector cell-associated neurotoxicity syndrome (ICANS). No treatment-related deaths occurred.
More news about: CARsgen Therapeutics
Oct 02, 2025, 08:30 ET Celltrion launches AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in the United States
July 2025, the FDA approved an additional indication for the intravenous (IV) formulation of AVTOZMA for the treatment of cytokine release syndrome (CRS) in adult and pediatric patients aged two years and older. INDICATION AVTOZMA® (tocilizumab-anoh)
More news about: Celltrion
Oct 01, 2025, 14:00 ET Beyond Expectations: Kubota Unveils Next-Generation Grand L70 Series Compact Tractors
hp, empowering operators to tackle a wide variety of jobs with power, confidence and efficiency. The Grand L70 utilizes Kubota's Common-Rail System (CRS) with electronically controlled fuel injection for smooth, efficient operation. Both models are available in 3- or 4-cylinder configurations; the deluxe
More news about: Kubota Tractor Corporation
Oct 01, 2025, 07:30 ET IBS Software Unveils AI-Powered Virtual Agents to Transform Air Cargo at 25th Cargo Forum
management. Across the hospitality sector, IBS Software offers a cloud-native, unified platform for hotels and travel sellers, including central reservation (CRS), property management (PMS), revenue management (RMS), call centre, booking engine, loyalty, and distribution. For the tour & cruise industry, IBS
More news about: IBS Software
Oct 01, 2025, 07:00 ET Public Launches Fully Customizable Direct Indexing
Form CRS, and
More news about: Public
Sep 23, 2025, 08:00 ET Dominari Holdings Announces Board Member Tim Ledwick to Assume Role of Interim Chief Financial Officer
all of the principal invested. You can check the background of Dominari Securities and its registered investment professionals and review its SEC Form CRS on FINRA's BrokerCheck site at
More news about: Dominari Holdings Inc.
Sep 22, 2025, 11:02 ET CellPoint Digital lanza One Source Orchestration, la primera plataforma de optimización de pagos para satisfacer la demanda de los modelos de venta minorista OOSD
que manejan la industria de viajes, incluidos los sistemas de distribución global (GDS, por sus siglas en inglés), los sistemas centrales de reservas (CRS), los sistemas de gestión de propiedades (PMS), los sistemas de gestión de ofertas y los conectores previamente construidos para los sistemas de servicio
More news about: CellPoint Digital
Sep 22, 2025, 01:00 ET CellPoint Digital Launches One Source Orchestration, the First Payment Optimization Platform to Meet the Demand of OOSD Retailing Models
friction. OSO also integrates with the core systems that run the travel industry, including Global Distribution Systems (GDS), Central Reservation Systems (CRS), Property Management Systems (PMS), Offer Management Systems, and features pre-built connectors to airline Passenger Service Systems (PSS). It can be
More news about: CellPoint Digital
Sep 22, 2025, 01:00 ET CellPoint Digital Launches One Source Orchestration, the First Payment Optimization Platform to Meet the Demand of OOSD Retailing Models
friction. OSO also integrates with the core systems that run the travel industry, including Global Distribution Systems (GDS), Central Reservation Systems (CRS), Property Management Systems (PMS), Offer Management Systems, and features pre-built connectors to airline Passenger Service Systems (PSS). It can be
More news about: CellPoint Digital
Sep 19, 2025, 08:30 ET TECVAYLI® and DARZALEX FASPRO®-based induction treatment demonstrates promising rates and depths of response in transplant-eligible patients with newly diagnosed multiple myeloma
release syndrome (CRS), including life-threatening or fatal reactions. In the clinical trial, CRS occurred in 72% of patients who received TECVAYLI® at the recommended dose, with Grade 1 CRS occurring in 50% of patients, Grade 2 in 21%, and Grade 3 in 0.6%. Recurrent CRS occurred in 33% of
More news about: Johnson & Johnson
Sep 19, 2025, 08:00 ET Antengene to Present Latest Preclinical Results from ATG-201 (CD19xCD3 TCE) at ACR 2025
for low-expressing targets, steric hindrance masking, and proprietary CD3 sequences with fast on/off kinetics to minimize cytokine release syndrome (CRS) and enhance efficacy. These characteristics support the platform's broad applicability across autoimmune diseases, solid tumors and hematological
More news about: Antengene Corporation Limited
Sep 19, 2025, 08:00 ET Antengene to Present Latest Preclinical Results from ATG-201 (CD19xCD3 TCE) at ACR 2025
for low-expressing targets, steric hindrance masking, and proprietary CD3 sequences with fast on/off kinetics to minimize cytokine release syndrome (CRS) and enhance efficacy. These characteristics support the platform's broad applicability across autoimmune diseases, solid tumors and hematological
More news about: Antengene Corporation Limited
Sep 18, 2025, 21:39 ET 2025 IMS | IASO Bio Highlights Three-Year Follow-Up Data of CAR-T Cell Therapy Fucaso for Multiple Myeloma Treatment
achieved CR or sCR, the median duration of MRD negativity was 36.5 months. Manageable long-term safety profile CRS occurred in 93.6% of patients, with only one case≥grade 3;ICANS was reported in two patients (grade 1–2);No late-onset neurotoxicity
More news about: IASO Bio
Sep 17, 2025, 20:15 ET CARsgen Presents Updated Long-term Follow-up Results for Zevor-cel at IMS 2025
median follow-up duration was 53.3 months (range:14.8, 63.5). Regarding safety: There were no reports of ≥Grade 3 cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), delayed neurotoxicities, second primary malignancy or other delayed AEs on the study.
More news about: CARsgen Therapeutics
Sep 17, 2025, 17:09 ET MagicRNA's First-in-Human Clinical Data Demonstrating Feasibility of In Vivo CAR T Therapy in Systemic Lupus Erythematosus Published in The New England Journal of Medicine.
much as 20 points in all 5 patients 3 months after the infusion of HN2301. The treatment was generally well tolerated, no patients experienced grade ≥3 CRS, and no neurotoxic effects or other severe adverse events were observed during or after treatment. Based on these encouraging clinical results,
More news about: Shenzhen MagicRNA Biotech Co., Ltd.
Sep 17, 2025, 05:00 ET IBS Software and Emirates Skywards Launch Strategic Partnership and Successfully Deploy Next-Gen iLoyal Loyalty Platform
management. Across the hospitality sector, IBS Software offers a cloud-native, unified platform for hotels and travel sellers, including central reservation (CRS), property management (PMS), revenue management (RMS), call centre, booking engine, loyalty, and distribution. For the tour & cruise industry, IBS
More news about: IBS Software
Sep 15, 2025, 07:01 ET Amadeus and Shiji partner to offer hotels a complete hospitality technology suite
providing new single-image integrations, we are offering an unparalleled solution that addresses historical fragmentation and delivers the best in PMS, POS, CRS, sales and catering, and hotel operations technology." About Amadeus Amadeus makes the experience of travel better for everyone,
More news about: Shiji Group